var data={"title":"Terbinafine (topical): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Terbinafine (topical): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/8194?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=terbinafine-topical-drug-information\" class=\"drug drug_general\">see &quot;Terbinafine (topical): Drug information&quot;</a> and <a href=\"topic.htm?path=terbinafine-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Terbinafine (topical): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566190\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>LamISIL Advanced [OTC];</li>\n      <li>LamISIL AT Jock Itch [OTC];</li>\n      <li>LamISIL AT Spray [OTC];</li>\n      <li>LamISIL AT [OTC];</li>\n      <li>LamISIL Spray [DSC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566191\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Lamisil</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F994503\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antifungal Agent, Topical</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F994514\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=terbinafine-topical-drug-information\" class=\"drug drug_general\">see &quot;Terbinafine (topical): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pityriasis</b>\n      <b> (tinea) versicolor: </b>Limited data available: Children &ge;12 years and Adolescents: Topical: Solution (spray): Apply to affected area once daily for 1 week (Bradley 2017; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea corporis (ringworm)</b>: Children &ge;12 years and Adolescents: Topical: Cream, gel: Apply to affected area once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea cruris (jock itch):</b> Children &ge;12 years and Adolescents: Topical: Cream, gel, solution (spray): Apply to affected area once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea pedis (athlete&rsquo;s foot): </b>Children &ge;12 years and Adolescents: Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply between the toes to affected area twice daily for at least 1 week; apply on the bottom or sides of feet twice daily for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply to affected area once daily at bedtime for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea corporis, Tinea cruris:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Solution: Apply to affected area once daily for 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Tinea pedis:</b> Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream: Apply between the toes to affected area once or twice daily for at least 1 week; apply on the bottom or sides of feet twice daily for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gel: Apply to affected area once daily for at least 1 week</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Solution: Apply to affected area once daily for at least 1 week</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247718\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT: 1% (12 g, 24 g, 30 g, 36 g, 42 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT Jock Itch: 1% (12 g) [contains benzyl alcohol, cetyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (12 g [DSC], 15 g, 24 g [DSC], 30 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL Advanced: 1% (12 g) [contains alcohol, usp]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as hydrochloride: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL AT Spray: 1% (30 mL [DSC], 125 mL) [contains alcohol, usp, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">LamISIL Spray: 1% (30 mL [DSC]) [contains alcohol, usp]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566194\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10526788\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">For external use only; avoid contact with eyes or mouth. Do not use on nails, scalp, or for vaginal yeast infections. Apply to clean, dry affected area in sufficient quantity to cover. Wash hands after use.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568017\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel: Store at &le;30&deg;C (&le;86&deg;F).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution: Store at 8&deg;C to 25&deg;C (46&deg;F to 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F994504\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm) (OTC: FDA approved in ages &ge;12 years and adults); has also been used for treatment of pityriasis versicolor (formerly tinea versicolor)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9566186\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Terbinafine may be confused with terbutaline</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568010\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Burning sensation of skin, contact dermatitis, exfoliation of skin, pruritus, skin irritation, skin rash, stinging of the skin, xeroderma</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Local: Local irritation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9601565\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">There are no contraindications listed within the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Canadian labeling:</i> Hypersensitivity to terbinafine or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247709\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse events:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Local irritation: If irritation/sensitivity develops, discontinue therapy and institute appropriate alternative therapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: For topical use only. Not intended for ophthalmologic, oral, or vaginal administration. Do not use on nails or scalp.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26522920\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300113\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247713\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=15935&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9568004\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events were not observed in animal reproduction studies with systemic terbinafine. Systemic absorption is limited following topical application. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247707\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Synthetic allylamine derivative that inhibits squalene epoxidase, a key enzyme in sterol biosynthesis in fungi. This results in a deficiency in ergosterol within the fungal cell membrane and results in fungal cell death.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F247721\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Limited (&lt;5%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Distributed to sebum and skin predominantly</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 14 to 35 hours </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9572927\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (LamISIL AT External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.58</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (LamISIL AT Jock Itch External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Terbinafine HCl External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $11.99</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (LamISIL Advanced External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (12 g): $8.72</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (LamISIL AT Spray External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (125 mL): $8.93</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961914\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Amizil (PH);</li>\n      <li>Antifan (CZ, EE);</li>\n      <li>Binter (LK);</li>\n      <li>Derfin (BD);</li>\n      <li>Dermasil (IL);</li>\n      <li>Dermifene (PH);</li>\n      <li>Farbcil (GT);</li>\n      <li>Farbicil (CR, DO, HN, NI, PA, SV);</li>\n      <li>Finex (PY);</li>\n      <li>Fintrix (LK);</li>\n      <li>Fungasil (IE, MT);</li>\n      <li>Funginix (DK);</li>\n      <li>Fungizid (DE);</li>\n      <li>Fungster (BE);</li>\n      <li>Funide (EC);</li>\n      <li>Futeshu (CN);</li>\n      <li>Hifen (VN);</li>\n      <li>Interbi (HK, ID);</li>\n      <li>Lamater (IE);</li>\n      <li>Lamifen (AE, JO, PH, QA, SA);</li>\n      <li>Lamisil (AE, AR, AT, AU, BE, BG, BH, BR, CH, CL, CO, CY, CZ, DK, EE, EG, ES, ET, FI, FR, GB, GR, HK, HR, ID, IL, IS, IT, JO, KR, KW, LB, LT, LU, LV, MT, MY, NL, NO, PE, PH, PK, PL, PT, PY, QA, RO, RU, SA, SE, SG, SI, SK, TH, TR, TW, UY, ZW);</li>\n      <li>Lamisil AT (ID);</li>\n      <li>Lamisil Once (AE, AU, HK, KW, LB, PH, QA, SA, TH);</li>\n      <li>Lamisilate (FR);</li>\n      <li>Lamizyl (UA);</li>\n      <li>Lan Meishu (CN);</li>\n      <li>Lisim (SG);</li>\n      <li>Medisil (QA);</li>\n      <li>Micoset (CL);</li>\n      <li>Micozone (EC);</li>\n      <li>Mujonal (CN);</li>\n      <li>Murazol (KR);</li>\n      <li>Mycelvan (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Otenol (MY);</li>\n      <li>Patir (IL);</li>\n      <li>Periafin (TW);</li>\n      <li>Ronasil Derm Gel (KR);</li>\n      <li>Sebifin (IN);</li>\n      <li>Skinabin (BD);</li>\n      <li>SolvEasy Tinea (AU, NZ);</li>\n      <li>Terafan (ET);</li>\n      <li>Terbasil (IE);</li>\n      <li>Terbex (BD);</li>\n      <li>Terbifin (BD, ZW);</li>\n      <li>Terbinorm (UA);</li>\n      <li>Terbisan (LK);</li>\n      <li>Terbisil (MT);</li>\n      <li>Terekol (AR);</li>\n      <li>Terfex (VE);</li>\n      <li>Terfina (QA);</li>\n      <li>Terfine (TW);</li>\n      <li>Terfung (TW);</li>\n      <li>Tiersil Once (KR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-pediatric-drug-information/abstract-text/11487763 /pubmed\" target=\"_blank\" id=\"11487763 \">11487763 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2015 Report of the Committee on Infectious Diseases</i>. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bradley JS, Nelson JD, Barnett E, et al. <i>Nelson's Pediatric Antimicrobial Therapy</i>. 23rd ed. American Academy of Pediatrics; 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lamisil AT Antifingal gel (terbinafine, topical) [prescribing information]. Parsippany, NJ: Novartis Consumer Health, Inc.; January 2010.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lamisil AT cream (terbinafine, topical) [prescribing information]. Warren, NJ: GSK Consumer Healthcare; May 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lamisil AT spray (terbinafine, topical) [prescribing information]. Parsippany, NJ: Novartis Consumer Health, Inc.; January 2010.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/terbinafine-topical-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 15935 Version 104.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F9566190\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F9566191\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F994503\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F994514\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F247718\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F9566194\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F10526788\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F9568017\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F994504\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F9566186\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F9568010\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F9601565\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F247709\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26522920\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300113\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F247713\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F9568004\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F247707\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F247721\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F9572927\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961914\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/15935|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=terbinafine-topical-drug-information\" class=\"drug drug_general\">Terbinafine (topical): Drug information</a></li><li><a href=\"topic.htm?path=terbinafine-topical-patient-drug-information\" class=\"drug drug_patient\">Terbinafine (topical): Patient drug information</a></li></ul></div></div>","javascript":null}